Novartis AG 2010 AR2
The report highlights Novartis' financial and operational performance for the fiscal year 2010, achieving record net sales of USD 50.6 billion, driven by strong growth across all divisions and the consolidation of Alcon, Inc. The company advanced its industry-leading pipeline with key regulatory approvals, including Gilenya for multiple sclerosis and Tasigna for chronic myeloid leukemia. In corporate citizenship, Novartis expanded its access-to-medicine programs, reaching 85 million patients in need and investing USD 1.5 billion in healthcare initiatives. Additionally, the company made significant progress in environmental sustainability, improving energy efficiency by 26% since 2006 and reducing fleet CO2 emissions.
Company: Novartis AG
Sector: Manufacturing
Country: Switzerland
Year: 2010
Type: AR2
Pages: 274
Back to company
Novartis AG
Annual Report
The report highlights Novartis' financial and operational performance for the fiscal year 2010, achieving record net sales of USD 50.6 billion, driven by strong growth across all divisions and the consolidation of Alcon, Inc. The company advanced its industry-leading pipeline with key regulatory approvals, including Gilenya for multiple sclerosis and Tasigna for chronic myeloid leukemia. In corporate citizenship, Novartis expanded its access-to-medicine programs, reaching 85 million patients in need and investing USD 1.5 billion in healthcare initiatives. Additionally, the company made significant progress in environmental sustainability, improving energy efficiency by 26% since 2006 and reducing fleet CO2 emissions.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2010
Reporting Period
Jan 1, 2010 - Dec 31, 2010
Fiscal Year
2010
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees